By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Cellular Biomedicine Group 

530 University Avenue
Suite 17
Palo Alto  California  94301  U.S.A.
Phone: 1-650-566-5064 Fax: n/a



Company News
Cellular Biomedicine Group (CBMG) Reports Second Quarter And First Half 2017 Financial Results And Business Highlights 8/9/2017 1:21:56 PM
Cellular Biomedicine Group (CBMG) Appoints Dr. Xia Meng As Chief Operating Officer To Lead Commercialization Of The Company‚Äôs CAR-T And Stem Cell Products 6/26/2017 11:07:50 AM
Cellular Biomedicine Group (CBMG) Appoints Michael A. Caligiuri, MD As Chair Of External Advisory Board 6/20/2017 10:31:34 AM
Cellular Biomedicine Group (CBMG) (CBMG) Announces Publication Titled "Target Cell Killing Effects Of CD20 Targeting Chimeric Antigen Receptor T Cells Derived From The Type Ii Anti-CD20 Antibody" In Conjunction With 2017 ASCO Annual Meeting 5/22/2017 12:25:15 PM
Cellular Biomedicine Group (CBMG) And GE Healthcare Life Sciences China Announce Strategic Partnership To Establish Joint Technology Laboratory To Develop Control Processes For The Manufacture Of CAR-T And Stem Cell Therapies 4/10/2017 8:49:42 AM
Cellular Biomedicine Group (CBMG) Announces Completion Of Wuxi GMP Facility Expansion 3/30/2017 12:14:17 PM
Cellular Biomedicine Group (CBMG) Awarded $2.29 Million Grant From The California Institute For Regenerative Medicine (CIRM) To Fund AlloJoin Allogeneic Stem Cell Therapy For Knee Osteoarthritis (KOA) In The U.S. 2/27/2017 8:03:27 AM
Cellular Biomedicine Group (CBMG), A China-US Biopharma, Starts China Trial Of CAR-T Immunotherapy 12/1/2016 9:08:33 AM
Cellular Biomedicine Group (CBMG) Lands $43 Million From Wuhan Dangdai 2/8/2016 9:06:05 AM
Cellular Biomedicine Group (CBMG) To Present At The Piper Jaffray 27th Annual Healthcare Investor Conference 11/24/2015 10:53:05 AM